NASD · Healthcare · Medical Devices · USA
Inogen Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.
Inogen Inc develops, manufactures, and markets respiratory health products for patients with chronic respiratory conditions. Its primary offerings include portable oxygen concentrators such as the Inogen One and Inogen Rove systems, the Simeox airway clearance device, a stationary oxygen concentrator, and CPAP masks. The company serves patients globally requiring long-term oxygen therapy and airway clearance treatment.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Inogen Inc stock.
Slightly undervalued: intrinsic value $6.86 per share, market price $5.68, margin of safety 17.1% (as of 2026-11-17).
Its through-the-cycle earnings (4.0% median margin), capitalised at 11.2% with no growth, values the shares at $6.86; the price of $5.68 is 17% below that value.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
8 more in this industry show a wider margin of safety.
INGN is slightly undervalued (as of the 2026-11-17 close). Its through-the-cycle earnings (4.0% median margin), capitalised at 11.2% with no growth, values the shares at $6.86; the price of $5.68 is 17% below that value.
$6.86 per share (as of the 2026-11-17 close), against a market price of $5.68. That is a margin of safety of 17.1%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.